Suzhou Baimai Biopharmaceutical Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Suzhou Baimai Biopharmaceutical Co., Ltd. - overview
Established
2019
Location
Suzhou, Jiangsu, China
Primary Industry
Biotechnology
About
Established in 2019, Suzhou Baimai Biopharmaceutical Co. , Ltd. is a pharmaceutical company focusing on the platform of biomaterial technology. Currently, it has realized the Lincese out business cooperation of an early product and has a self-initiated pipeline, BM201, approved for IND and about to enter Phase I clinical.
The founder Zhuang Liu has been working in the field of biomaterials for more than ten years. The company focuses on innovative drugs and agents for the treatment of diseases such as oncology and cancer and provides immunotherapy treatment options. The development pipeline includes the long-acting extended-release formulation BM201, the ICD-chemical combination formulations BM101 and BM221, and the multichannel immune agonist BM501.
Current Investors
LH Ventures, YuanBio Venture, Gongshan Fund
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Oncology/Cancer Treatment, Pharmaceutical Research & Development, Specialty Pharmaceuticals
Verticals
HealthTech
Company Stage
Series A
Total Amount Raised
Subscriber access only
Suzhou Baimai Biopharmaceutical Co., Ltd. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Unspecified Round | Completed | Suzhou Baimai Biopharmaceutical Co., Ltd. | - | ||||||||
| Series A | Completed | Suzhou Baimai Biopharmaceutical Co., Ltd. | - | ||||||||
| Series A | Completed | Suzhou Baimai Biopharmaceutical Co., Ltd. | - |
Displaying 1 - 3 of 3
Suzhou Baimai Biopharmaceutical Co., Ltd. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.